DNA copy number changes define spatial patterns of heterogeneity in colorectal cancer

[1]  Ulf Leser,et al.  SoFIA: a data integration framework for annotating high-throughput datasets , 2016, Bioinform..

[2]  Debashis Sahoo,et al.  CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. , 2016, The New England journal of medicine.

[3]  R. Scharpf,et al.  The Genomic Landscape of Response to EGFR Blockade in Colorectal Cancer , 2015, Nature.

[4]  C. Curtis,et al.  Many private mutations originate from the first few divisions of a human colorectal adenoma , 2015, The Journal of pathology.

[5]  M. Kloor,et al.  Distinctive Spatiotemporal Stability of Somatic Mutations in Metastasized Microsatellite-stable Colorectal Cancer , 2015, The American journal of surgical pathology.

[6]  Ash A. Alizadeh,et al.  Toward understanding and exploiting tumor heterogeneity , 2015, Nature Medicine.

[7]  Lawrence D. True,et al.  Integrative Clinical Genomics of Advanced Prostate Cancer , 2015, Cell.

[8]  Charles Swanton,et al.  Translational Implications of Tumor Heterogeneity , 2015, Clinical Cancer Research.

[9]  Masakazu Yamamoto,et al.  Molecular Biomarkers for Progression of Intraductal Papillary Mucinous Neoplasm of the Pancreas , 2015, Pancreas.

[10]  C. Curtis,et al.  A Big Bang model of human colorectal tumor growth , 2015, Nature Genetics.

[11]  Pieter Wesseling,et al.  DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly , 2014, Genome research.

[12]  J. Foidart,et al.  EGFR activation and signaling in cancer cells are enhanced by the membrane-bound metalloprotease MT4-MMP. , 2014, Cancer research.

[13]  Shibing Deng,et al.  Patterns of somatic alterations between matched primary and metastatic colorectal tumors characterized by whole-genome sequencing. , 2014, Genomics.

[14]  Vladimir Vacic,et al.  Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions , 2014, Genome Biology.

[15]  Bert Vogelstein,et al.  DETECTION OF CIRCULATING TUMOR DNA IN EARLY AND LATE STAGE HUMAN MALIGNANCIES , 2014 .

[16]  Liam O'Connor,et al.  Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer. , 2014, Cancer research.

[17]  K. Polyak.  Tumor Heterogeneity Confounds and Illuminates: A case for Darwinian tumor evolution , 2014, Nature Medicine.

[18]  S. Lee,et al.  Comparative Genomic Analysis of Primary and Synchronous Metastatic Colorectal Cancers , 2014, PloS one.

[19]  Peter Ulz,et al.  Changes in Colorectal Carcinoma Genomes under Anti-EGFR Therapy Identified by Whole-Genome Plasma DNA Sequencing , 2014, PLoS genetics.

[20]  E. Rozenblum,et al.  Multi-Layered Cancer Chromosomal Instability Phenotype , 2013, Front. Oncol..

[21]  G. Getz,et al.  A Genomics-Based Classification of Human Lung Tumors , 2013, Science Translational Medicine.

[22]  Benjamin J. Raphael,et al.  Mutational landscape and significance across 12 major cancer types , 2013, Nature.

[23]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[24]  Masaru Ishii,et al.  CognitionMaster: an object-based image analysis framework , 2013, Diagnostic Pathology.

[25]  Sridhar Ramaswamy,et al.  Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..

[26]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2013 , 2012, Nucleic Acids Res..

[27]  A. McCullough.  Comprehensive molecular characterization of human colon and rectal cancer , 2013 .

[28]  Melanie A. Huntley,et al.  Recurrent R-spondin fusions in colon cancer , 2012, Nature.

[29]  Enzo Medico,et al.  Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer , 2012, Nature.

[30]  Johannes G. Reiter,et al.  The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers , 2012, Nature.

[31]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[32]  Eric S. Lander,et al.  Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing , 2012, Proceedings of the National Academy of Sciences.

[33]  J. Walter,et al.  A fast, cost‐efficient and sensitive approach for KRAS mutation detection using multiplexed primer extension with IP/RP‐HPLC separation , 2012, International journal of cancer.

[34]  R. Arceci.  Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing , 2012 .

[35]  Ping Wang,et al.  Identification of genes with a correlation between copy number and expression in gastric cancer , 2012, BMC Medical Genomics.

[36]  Mei Xu,et al.  CDX2 as a marker for intestinal differentiation: Its utility and limitations. , 2011, World journal of gastrointestinal surgery.

[37]  Kristian Cibulskis,et al.  Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion , 2011, Nature Genetics.

[38]  Nicolai J. Birkbak,et al.  Chromosomal instability confers intrinsic multidrug resistance. , 2011, Cancer research.

[39]  E. Fearon.  Molecular genetics of colorectal cancer. , 2011, Annual review of pathology.

[40]  Mingming Jia,et al.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..

[41]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2011 , 2010, Nucleic Acids Res..

[42]  Z. Szallasi,et al.  Targeting chromosomal instability and tumour heterogeneity in HER2‐positive breast cancer , 2010, Journal of cellular biochemistry.

[43]  M. Nowak,et al.  Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.

[44]  R. McIntyre,et al.  The activating mutation R201C in GNAS promotes intestinal tumourigenesis in ApcMin/+ mice via activation of Wnt and ERK1/2 MAPK pathways , 2010, Oncogene.

[45]  M. Gönen,et al.  Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. , 2010, The Journal of clinical investigation.

[46]  Outi Monni,et al.  Genome-wide gene copy number and expression analysis of primary gastric tumors and gastric cancer cell lines , 2010, BMC Cancer.

[47]  S. Tavaré,et al.  Many colorectal cancers are “flat” clonal expansions , 2009, Cell cycle.

[48]  F. Klauschen,et al.  Computational reconstruction of cell and tissue surfaces for modeling and data analysis , 2009, Nature Protocols.

[49]  Thomas J. Hardcastle,et al.  Chromosomal instability determines taxane response , 2009, Proceedings of the National Academy of Sciences.

[50]  M. Speicher,et al.  Defining 'chromosomal instability'. , 2008, Trends in genetics : TIG.

[51]  M. Baudis.  Genomic imbalances in 5918 malignant epithelial tumors: an explorative meta-analysis of chromosomal CGH data , 2007, BMC Cancer.

[52]  Hidetoshi Shimodaira,et al.  Pvclust: an R package for assessing the uncertainty in hierarchical clustering , 2006, Bioinform..

[53]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[54]  M. Owen,et al.  Genotyping single nucleotide polymorphisms by primer extension and high performance liquid chromatography , 1999, Human Genetics.